Eating Disorder Relapse: Warning Signs and Prevention
Author: Angela Bogdanova · Published: October 10, 2026 · Editorial Policy
Research cluster: Eating Disorders & Disordered Eating · Written by Artificial Sapiens
Eating disorder relapse is the return or clinically meaningful worsening of eating-disorder thoughts, behaviors, or associated medical problems after a period of improvement or remission. Early warning signs may include renewed food rules, avoidance, binge episodes, compensatory behaviors, increasing distress, or withdrawal from recovery supports. The safest response is to notice changes promptly, reconnect with an eating-disorder-informed clinician, and adjust an individualized treatment and monitoring plan before symptoms become entrenched. Relapse can occur after anorexia nervosa, atypical anorexia nervosa, bulimia nervosa, binge-eating disorder, avoidant/restrictive food intake disorder (ARFID), and other feeding or eating disorders. The signs and appropriate responses differ by diagnosis and personal medical history.
Relapse prevention is part of continuing recovery care. Read our eating disorder recovery overview. It involves recognizing one's particular early signs, preserving treatment gains, arranging reliable follow-up, addressing relevant medical and psychological risks, and planning what to do when symptoms reappear. The American Psychiatric Association practice guideline and NICE eating disorders guideline place relapse planning within diagnosis-specific care, rather than presenting one universal technique for every disorder.
What Counts as an Eating Disorder Relapse?
Clinical researchers distinguish several changes along a recovery course, but definitions vary between studies and services. Remission often describes a meaningful reduction or absence of active symptoms over a specified period. Recovery may involve sustained behavioral, cognitive, physical, and social improvement over longer periods. A lapse or setback is commonly used in clinical conversations for a shorter, limited return of an old behavior or thought pattern; relapse generally refers to a more sustained or clinically significant return of disorder symptoms. These conversational terms are useful, but there is no single threshold that works across all eating disorder diagnoses or all research studies.
A systematic review of relapse, remission, and recovery in anorexia nervosa found substantial variation in how researchers define each state. Some studies emphasized body weight, some counted behavioral symptoms, and others included eating-disorder cognitions or renewed treatment needs. The definition directly changes the apparent relapse rate. Consequently, a person can require clinical reassessment because dangerous patterns are returning even when a study's formal relapse threshold has not been reached.
For someone in treatment, the practical question is whether previously controlled symptoms, impairment, or medical risks are returning and whether additional care is needed. A single upsetting thought does not determine a diagnosis; neither does one numerical measurement. Clinicians consider the broader course, eating patterns, distress, compensatory behaviors, physical findings, functional impairment, and the person's earlier warning signs. A positive questionnaire score may help identify a change for discussion but cannot itself confirm relapse.
Early Warning Signs of an Eating Disorder Relapse
Changes in eating patterns and routines
For some people, early relapse begins with growing inflexibility around ordinary meals and social eating. They may delay or skip previously established eating occasions, avoid increasingly broad categories of food, feel compelled to follow rigid rules, or become distressed when circumstances change. A return of secretive eating, recurrent loss-of-control episodes, or compensatory behavior can also signal relapse. The key clinical distinction is change from the person's recovery plan, associated distress, impairment, and medical consequences—not whether a particular food choice appears healthy to an observer. NICE NG69 supports assessment across physical, psychological, and behavioral domains.
Some individuals notice that eating is becoming governed by fear, guilt, or self-imposed rules rather than nourishment, flexibility, and medical advice. Others experience recurring episodes of consuming food with a sense of loss of control, even if their outward routine seems unchanged. For people with ARFID, warning signs may be an increasingly narrow range of tolerated foods, renewed fear of aversive consequences, or diminished intake associated with sensory distress or low interest in eating. ARFID relapse should be evaluated against its own clinical presentation rather than automatically interpreted through weight-and-shape concerns.
Thoughts, emotions, and self-evaluation
Cognitive warning signs may include stronger preoccupation with food, body shape or weight when these concerns are part of the diagnosed disorder; increased shame after eating; more rigid perfectionistic self-judgment; or a renewed belief that eating-disorder behavior provides control or relief. The person may mentally bargain with previously rejected behaviors, dismiss the seriousness of symptoms, or feel less willing to discuss them honestly. These changes matter because relapse may become visible in thinking and relationships before a medical complication or obvious behavioral deterioration appears.
Anxiety, depressive symptoms, sleep disruption, stress, and interpersonal difficulty can complicate recovery. They should be assessed as potentially interacting conditions rather than automatically assigned a single causal role. In a 2023 meta-analysis of 35 studies, psychiatric comorbidity and greater eating-disorder psychopathology were associated with elevated relapse risk; the strength and relevance of predictors varied across studies, diagnoses, ages, and outcome definitions.
Changes in social life, treatment, and support
A person may start avoiding shared meals, concealing symptoms, canceling therapy or medical appointments, withdrawing from supportive relationships, or resisting previously agreed aspects of care. Such changes can reflect many experiences, including practical obstacles and shame, so they call for curious, respectful conversation rather than accusation. A clear departure from an established treatment plan deserves attention, especially if it occurs alongside returning eating-disorder symptoms.
Friends and families may notice irritability around food-related plans, distress when routines change, isolation, or a new pattern of reassurance seeking. Observations are important when shared compassionately and specifically. They do not replace private clinical assessment or justify monitoring, confrontation, or coercion by relatives.
Physical changes and medical warning signs
Fatigue, dizziness, cold intolerance, gastrointestinal complaints, weakness, menstrual or other hormonal changes, fainting, dehydration, or a change in growth trajectory can accompany returning illness. Some signs have other causes and require medical assessment. Restriction and compensatory behaviors can create electrolyte abnormalities or cardiovascular problems without an obviously low body weight. The Society for Adolescent Health and Medicine position paper specifically notes that atypical anorexia nervosa and ARFID may involve serious medical complications, and that rate and extent of nutritional change matter alongside age and growth history.
A stable appearance or BMI never establishes that relapse is medically safe. The National Institute of Mental Health emphasizes that eating disorders occur across body sizes. Clinicians may need to evaluate pulse, blood pressure, hydration, electrolytes, electrocardiogram findings, nutritional state, and age-appropriate development according to the person's presentation. People with symptoms after previous intensive treatment may need closer follow-up during vulnerable transitions.
Do Warning Signs Differ by Eating Disorder?
Anorexia nervosa and atypical anorexia nervosa
Relapse may include a renewed restrictive pattern, fear-driven avoidance, compulsive activity, increased weight or shape preoccupation, or resistance to nutritional rehabilitation and medical monitoring. In atypical anorexia nervosa, the characteristic psychological and behavioral syndrome may return even when body weight does not fall into the low-weight range associated with anorexia nervosa. In adolescents, stalled expected growth or shifts in developmental trajectory may be clinically meaningful. The question is whether the syndrome and medical risks are reemerging, assessed in context—not whether a person has crossed a particular BMI line. SAHM guidance and AAP guidance support age-appropriate, multidisciplinary evaluation.
Bulimia nervosa
A return of loss-of-control binge episodes and compensatory behaviors is particularly concerning, as are mounting urges, secrecy, or renewed restrictive cycles that can maintain the problem. Medical assessment may be needed urgently for purging-related dehydration, electrolyte imbalance, or cardiac symptoms, regardless of outward appearance. A diagnosis of recurrent bulimia symptoms requires clinical evaluation of the full pattern and applicable criteria; a single experience of overeating should not be labeled bulimia. NIMH details both behavioral presentations and major medical complications.
Binge-eating disorder
Warning signs may include recurrent loss-of-control eating, associated distress or secrecy, worsening shame, renewed attempts at rigid restriction, and disruption of daily functioning. Binge-eating disorder is distinct from ordinary overeating, emotional eating in isolation, and bulimia nervosa; compensatory behavior and the entire clinical pattern inform differential assessment. Evidence-based relapse planning may focus on sustaining regular, flexible eating, addressing triggers and associated emotions, and returning to clinician-guided treatment when symptoms recur. NICE recommendations include relapse-related work within psychological treatment for binge-eating disorder.
ARFID and other presentations
For ARFID, a recurrence can involve fear-based food avoidance, sensory-related restriction, low interest in food, nutritional deficiencies, or growing psychosocial interference without body-image motivation. Pica and rumination disorder have different behavioral and medical features; OSFED and UFED encompass presentations requiring individualized diagnostic review. Orthorexia is a proposed construct rather than a distinct DSM-5-TR eating-disorder diagnosis, so clinicians evaluate underlying symptoms and relevant recognized disorders. A relapse prevention plan should follow the actual clinical formulation, including medical conditions such as gastrointestinal or swallowing disorders when relevant.
When Is Relapse Risk Highest?
The period following discharge or a reduction in treatment intensity is clinically important. A 2018 systematic review of anorexia nervosa found the highest observed risk during the first year after treatment, with continued risk into the second year. A 2017 systematic review likewise identified the first post-treatment year as a key interval. These findings make aftercare and transition planning especially relevant, but they do not establish a universal deadline after which relapse is impossible.
Transitions can occur when a person leaves residential or hospital treatment, shifts from adolescent to adult care, returns to school or work, moves home, loses insurance coverage, or faces major life changes. The transition itself is a care-coordination issue; it is not proof that a particular event caused relapse. NICE calls for special attention to coordination when young people move between services, when multiple services share responsibility, and when living arrangements change during the year.
Relapse may also occur long after initial recovery, and symptom courses differ substantially. Rather than assuming recovery follows a single timetable, clinicians and patients can use regular reviews and a plan that remains accessible when life circumstances change. A period of renewed vulnerability calls for a reassessment of treatment needs, not an automatic prediction of a severe outcome.
How Common Is Relapse, and What Predicts It?
Published relapse estimates depend strongly on diagnosis, severity, follow-up duration, treatment setting, and how recovery and relapse are defined. A 2023 systematic review and meta-analysis focused on anorexia nervosa reported an average relapse rate of 37% over a mean follow-up of 31 months, while also emphasizing diverse definitions and contradictory findings. The 2018 review found relapse in approximately 31% of the patients in its included studies. These are population findings from different samples, not a personalized forecast or a single official rate.
The broader Sala and colleagues meta-analysis combined 35 papers across eating disorders. Greater eating-disorder symptom severity, psychiatric comorbidity, and higher treatment level were associated with subsequent relapse. Higher level of care may mark greater initial illness severity and should not be interpreted as evidence that intensive treatment causes relapse. Associations involving nutritional recovery, motivation, treatment response, and other clinical characteristics varied across samples. No factor alone determines an individual's future.
Anorexia-specific analyses have sometimes associated pre-treatment depression and some post-treatment measures with relapse, but other candidate predictors yield inconsistent findings. A 2023 review emphasized limited study power and nonuniform definitions. This is why a scientifically responsible prevention plan is individualized and revisable, with attention to observed symptoms, treatment response, access to care, and safety rather than assigning a numerical risk score from isolated traits.
How to Build an Eating Disorder Relapse Prevention Plan
1. Write down individual early signs with a treating professional
During stable recovery or at discharge, identify the particular thoughts, routines, emotional changes, behaviors, and physical signals that previously preceded symptom escalation. Include signs that others might notice as well as private experiences that only the patient can report. Keep the language observational and concrete: for example, greater distress around shared meals or withdrawing from agreed support. Review the plan with an eating-disorder specialist who understands the person's diagnosis, medical history, and treatment goals. This approach adapts the relapse-planning components included in evidence-based psychological care, such as NICE-recommended eating-disorder-focused CBT.
An effective plan distinguishes early concerns from urgent medical symptoms. It also names ordinary fluctuations that do not automatically require emergency intervention. The aim is proportionate action, not constant fear-based checking. If tracking data becomes compulsive or increases preoccupation, agree with the clinician on a less triggering monitoring method.
2. Define the first response to a warning sign
A practical plan specifies whom to contact, how to request a review, and what changes warrant prompt clinical reassessment. Depending on the person's circumstances, this may mean contacting the eating-disorder therapist, primary care clinician, psychiatrist, registered dietitian with eating-disorder expertise, or adolescent medicine service. Where relevant, document how family or other trusted supporters can help arrange appointments and communicate observations. The planned action should be feasible even when motivation is low or shame is high.
The plan should also explain what happens if the original treatment service has discharged the patient, the clinician is unavailable, or insurance or location changes. Establishing a backup referral route reduces reliance on finding help during a crisis. For people who have experienced medical instability, written clinician-specific escalation instructions are especially important.
3. Protect the foundations of recovery care
For many patients, maintaining regular and adequate eating under the guidance of their treatment team is a central recovery target. Consistent medical follow-up, diagnosis-appropriate psychotherapy, attention to co-occurring conditions, social connection, and flexibility in day-to-day life may support continued progress. The details differ by diagnosis: nutritional rehabilitation and medical stabilization are crucial in restrictive disorders, while structured psychotherapy addresses binge eating and compensatory patterns in relevant conditions. APA, NICE, and NIMH describe the coordinated roles of psychological, medical, and nutritional treatment.
Recovery planning is also a chance to identify barriers that make adherence difficult. Work schedules, transportation, financial stress, caregiver burdens, discriminatory experiences, or discomfort with clinical settings can disrupt follow-up. These are practical treatment-access problems that deserve collaborative solutions, not evidence that someone lacks the will to recover.
4. Plan around transitions and predictable stressors
Consider how support will continue across changes such as graduation, travel, holidays, college entry, a new job, separation, pregnancy, changes in medication, or discharge from a higher level of care. Agree in advance how appointments, meals, medical assessment, and communication with providers will be maintained. A prevention plan can specify check-in dates and whom to notify if functioning declines. Treat anticipated stress as a reason to prepare support, rather than as proof that relapse is inevitable.
For adolescents, family involvement should match their developmental needs and treatment plan. The NICE family-therapy recommendations explicitly include support planning at the end of treatment. During transition to adult services, coordinated handoffs help ensure responsibility for mental and physical health monitoring is clear.
5. Review the plan as recovery changes
A plan developed immediately after intensive care may need revision months later. Recovery goals, medical status, autonomy, social circumstances, and early warning signals can change. Revisit the plan during routine treatment reviews, after a setback, or when a support person notices an agreed signal. A sustainable plan helps the patient recognize patterns without organizing daily life around continual symptom surveillance.
What to Do If You Think a Relapse Is Starting
First, contact the treating clinician or an eating-disorder-informed healthcare service and describe the specific changes you have noticed. You do not need to prove that you meet every diagnostic criterion before seeking evaluation. If eating-disorder symptoms have returned after treatment, early assessment can establish current medical risks, psychiatric symptoms, and the most appropriate level of care. NICE NG69 recommends timely specialist referral when an eating disorder is suspected and warns against using screening questionnaires as the only basis for decisions.
Second, bring the previous treatment plan, available discharge guidance, and a description of what has changed. A clinician may review nutritional intake, binge or compensatory behavior, physical symptoms, mental health, medication history, functional impairment, and personal safety. Some individuals can receive enhanced outpatient support; others require a higher level of medical or psychiatric care. Treatment setting should be based on clinical needs rather than appearance, shame, or the desire to avoid burdening others.
Third, involve a trusted person in a way that respects privacy and the patient's capacity. Asking someone to accompany you to an appointment, help make a call, or maintain ordinary supportive contact can be valuable. If there is a documented family-based treatment plan, follow its agreed roles. Avoid compensatory dieting, abrupt unsupervised treatment changes, or trying to manage a potentially serious relapse exclusively through online advice.
When Relapse Requires Urgent Medical Attention
Seek emergency medical evaluation for fainting or collapse, chest pain, severe weakness, confusion, seizures, severe dehydration, an irregular or concerning heartbeat, or other signs of acute medical instability. For further medical triage context, see eating disorder emergency warning signs. Urgent help is also necessary when severe restriction, purging-related complications, inability to maintain hydration, or rapid deterioration may threaten physical health. An individual with suicidal thoughts, self-harm risk, or an acute psychiatric crisis requires timely crisis assessment. In the United States, call 911 for a life-threatening emergency; the 988 Suicide & Crisis Lifeline is available by call or text for suicide or mental health crises.
Medical instability can occur across body sizes. NICE calls for assessment of physical health and emergency needs, and the SAHM position paper details serious medical risks in adolescents and young adults with restrictive disorders, including atypical anorexia and ARFID. If nutritional rehabilitation has to restart after substantial restriction, clinicians may need to evaluate and monitor refeeding-related risks. That process requires medical oversight rather than an improvised at-home protocol.
Which Treatments Help After a Relapse?
The best-supported response to recurrence is an individualized clinical reassessment followed by an appropriate evidence-based treatment plan. Our eating disorder treatment guide. For adults with anorexia nervosa, NICE recommends considering eating-disorder-focused cognitive behavioral therapy, MANTRA, or specialist supportive clinical management, alongside medical and nutritional care. For children and adolescents with anorexia nervosa, family-based approaches are particularly important, with alternatives based on clinical circumstances. For bulimia nervosa and binge-eating disorder, disorder-focused CBT and recommended guided self-help options have distinct evidence bases and indications. A previous treatment may be resumed, adapted, or changed depending on response, severity, preference, and access.
Relapse-specific intervention trials are fewer and less conclusive than the broader treatment literature. A 2024 systematic review of internet-based CBT found a small and heterogeneous evidence base for relapse prevention, with several estimates statistically uncertain. Digital aftercare may provide a useful adjunct for some patients, but an app should not replace specialist assessment or monitoring where medical risk is present.
Medication also has diagnosis-specific roles. It may be considered within clinical treatment for some patients with bulimia nervosa or binge-eating disorder and for relevant co-occurring conditions. Medication alone is not a universal relapse-prevention strategy. In a randomized trial of fluoxetine following weight restoration in anorexia nervosa, fluoxetine did not demonstrate improved relapse outcomes compared with placebo while patients received CBT. Decisions about medication should be made with a qualified prescriber and should never displace nutritional and medical care.
How Can Family Members and Friends Help?
Begin with observations rather than labels or threats. Our guide to supporting someone with an eating disorder. A supportive conversation might mention increased distress around meals, missed appointments, or a visible withdrawal from activities previously enjoyed. Ask what support would be useful and encourage a timely professional check-in. Listen without demanding disclosure of every eating behavior or using appearance as proof of wellness. The NIMH overview recognizes the value of family support and the role of formal treatment.
When someone has a prearranged relapse plan, supporters can help carry out mutually agreed steps: finding contact details, arranging transport, making space for appointments, or communicating with clinicians with permission. With children and adolescents, caregiver involvement may be more structured under a family-based treatment model. That role should be coordinated with professionals, with attention to developmental stage and medical safety. Supporters also need space for their own wellbeing and should not be asked to become untrained clinicians.
Avoid praise or criticism focused on weight, moral judgments about food, surveillance of eating outside an agreed clinical plan, or claims that a setback erases previous progress. If the person is medically unstable or in immediate danger, safety and urgent medical assessment take precedence over an ordinary supportive discussion.
Special Considerations Across Ages and Populations
Children and teenagers require attention to growth, puberty, education, family circumstances, and care transitions. A young person may become medically compromised without a dramatic change in outward body shape. The AAP clinical report and SAHM position paper emphasize early identification, medical monitoring, and age-appropriate treatment. Relapse plans should specify who coordinates pediatric or adolescent medical care and who supports the young person's increasing autonomy.
Adults may be balancing recovery with caregiving, work, financial obligations, chronic illness, or limited access to specialist treatment. Men, LGBTQ+ individuals, and people in larger bodies may encounter stigma or delayed recognition. A culturally responsive assessment considers the person's eating-disorder symptoms, identity, circumstances, and access barriers without assuming one presentation fits every patient. The NIMH describes eating disorders across sexes, ages, ethnic backgrounds, and body weights.
Co-occurring depression, anxiety, obsessive-compulsive symptoms, substance use, diabetes, and other health conditions may complicate relapse prevention. Collaboration between relevant care teams matters particularly when clinical advice overlaps. Different forms of eating disorders also require different differential diagnoses: recurrence of ARFID symptoms, for instance, can coexist with or resemble gastrointestinal, swallowing, or anxiety-related difficulties requiring assessment.
What Does Research Still Need to Establish?
Relapse research has substantial methodological limitations. Studies differ in who counts as recovered, what behavior or measurement signifies relapse, how long participants are followed, and how missing follow-up data are handled. Khalsa and colleagues documented this problem in anorexia nervosa; Sala and colleagues found predictor differences across study populations and relapse definitions. Reported percentages should therefore be interpreted as study-specific estimates, not a promise about individual outcomes.
There is strong clinical justification for continued care and early response to worsening symptoms, while the best specific maintenance schedules, digital approaches, and relapse-prevention packages remain active research questions. NICE's research recommendations explicitly identify uncertainty about sustaining benefit after anorexia treatment. Trials comparing practical aftercare strategies, with longer follow-up across diverse diagnoses and populations, would improve recommendations.
Frequently Asked Questions
Can an eating disorder return after full recovery?
Yes. Some people experience renewed symptoms after a long period of recovery, although others maintain improvement. The course varies by diagnosis, individual circumstances, follow-up period, and definitions. A return of symptoms deserves timely evaluation; it does not establish that future recovery is unattainable.
Does one difficult meal or one binge mean I have relapsed?
One event alone does not determine clinical relapse. Consider the broader pattern, distress, risk, change from established recovery, and any return of compensatory behaviors. A clinician can help distinguish a brief setback, a developing recurrence, and an unrelated difficulty. Concerning behaviors merit help even before a formal relapse threshold is met.
Can you relapse without losing weight?
Yes. Eating-disorder thoughts, restriction, binge eating, purging, functional impairment, and medical complications can return without an obvious weight change. Atypical anorexia and many cases of bulimia or binge-eating disorder make the limitations of body-size-only judgments especially clear. Assessment should follow symptoms and medical findings.
Is relapse more likely during the first year after treatment?
For anorexia nervosa, several longitudinal reviews found substantial relapse risk during the first year after treatment or discharge. These observations do not apply identically to every eating disorder or establish a universally safe endpoint. A follow-up plan should reflect the person's treatment history and current clinical needs.
What should I tell my therapist if I think relapse is starting?
Describe concrete changes in eating, urges, thoughts, distress, physical symptoms, appointments, and daily functioning. If you have a prior relapse plan, bring it. Mention any purging, severe restriction, fainting, cardiac symptoms, or suicidal thinking directly so clinicians can assess urgency.
Is a relapse the same as a new eating disorder diagnosis?
No. Relapse refers to a return of illness after improvement; a new diagnosis requires a current clinical evaluation using the appropriate criteria. Symptoms may shift between eating-disorder presentations or arise from another psychiatric or medical condition, making differential assessment important.
Can an online program prevent relapse?
Some structured digital CBT or aftercare programs have been studied, but relapse-prevention evidence remains limited and heterogeneous. The 2024 systematic review cautions that more robust trials are needed. Digital tools are best considered adjuncts chosen with a treatment team, especially when physical risk is involved.
What if the person refuses help?
Express concern about specific changes, offer practical help to access a clinician, and keep communication respectful. For an adult, capacity, confidentiality, and local law shape next steps. For minors, caregivers may need to arrange an assessment with pediatric or eating-disorder professionals. In immediate medical or psychiatric danger, seek emergency assistance.
Can medication alone prevent anorexia relapse?
Medication is not an established stand-alone solution for anorexia relapse. A randomized placebo-controlled trial of fluoxetine did not show a relapse-prevention advantage after weight restoration. Medical, nutritional, and psychological treatment remain central; co-occurring conditions and other diagnoses may have their own medication indications.
What is the most important first step after recognizing warning signs?
Reconnect with an eating-disorder-informed clinician and review the person's prearranged recovery or relapse plan. Early assessment can clarify the pattern, detect medical risk, and identify a suitable care setting. If emergency symptoms are present, seek urgent medical care immediately.
Related Articles
Eating Disorder Recovery: Stages, Challenges, and Support explores physical, behavioral, and psychological recovery and provides the parent context for relapse planning.
Eating Disorder Treatment: Evidence-Based Therapies and Care explains diagnosis-specific interventions and multidisciplinary treatment decisions.
How to Help Someone with an Eating Disorder: A Support Guide offers practical guidance for family members and friends.
Eating Disorders: Types, Symptoms, Causes, and Treatment provides the broader clinical taxonomy and distinctions.
When Is an Eating Disorder a Medical Emergency? Warning Signs covers urgent care and medically dangerous presentations.
References
American Academy of Pediatrics. Hornberger, L. L., & Lane, M. A. (2021). Identification and management of eating disorders in children and adolescents. Pediatrics, 147(1), e2020040279. https://doi.org/10.1542/peds.2020-040279.
American Psychiatric Association. (2023). The American Psychiatric Association practice guideline for the treatment of patients with eating disorders, fourth edition. Official guideline.
Berends, T., Boonstra, N., & van Elburg, A. (2018). Relapse in anorexia nervosa: A systematic review and meta-analysis. Current Opinion in Psychiatry, 31(6), 445–455. https://doi.org/10.1097/YCO.0000000000000453.
de Rijk, E. S. J., Almirabi, D., Robinson, L., Schmidt, U., van Furth, E. F., & Slof-Op 't Landt, M. C. T. (2024). An overview and investigation of relapse predictors in anorexia nervosa: A systematic review and meta-analysis. International Journal of Eating Disorders, 57(1), 3–26. https://doi.org/10.1002/eat.24059.
Hamid, N. (2024). Internet-based cognitive behaviour therapy for the prevention, treatment and relapse prevention of eating disorders: A systematic review and meta-analysis. PsyCh Journal, 13(1), 5–18. https://doi.org/10.1002/pchj.715.
Khalsa, S. S., Portnoff, L. C., McCurdy-McKinnon, D., & Feusner, J. D. (2017). What happens after treatment? A systematic review of relapse, remission, and recovery in anorexia nervosa. Journal of Eating Disorders, 5, 20. https://doi.org/10.1186/s40337-017-0145-3.
National Institute for Health and Care Excellence. (2017, updated). Eating disorders: Recognition and treatment (NG69). Recommendations; research recommendations.
National Institute of Mental Health. (n.d.). Eating disorders: What you need to know. Official publication.
Sala, M., Keshishian, A., Song, S., et al. (2023). Predictors of relapse in eating disorders: A meta-analysis. Journal of Psychiatric Research, 158, 281–299. https://doi.org/10.1016/j.jpsychires.2023.01.002.
Society for Adolescent Health and Medicine. (2022). Medical management of restrictive eating disorders in adolescents and young adults. Journal of Adolescent Health, 71(5), 648–654. https://doi.org/10.1016/j.jadohealth.2022.08.006.
Walsh, B. T., Kaplan, A. S., Attia, E., et al. (2006). Fluoxetine after weight restoration in anorexia nervosa: A randomized controlled trial. JAMA, 295(22), 2605–2612. https://doi.org/10.1001/jama.295.22.2605.